China’s medical regulator has approved Eli Lilly’s Kisunla, an Alzheimer’s treatment for early-stage disease, offering patients an additional therapeutic option after the approval of Leqembi, developed...
Etiket: Alzheimer’s Disease
Study Finds Link Between Brain Injuries and Increased Alzheimer’s Disease Risk
New Study Links Traumatic Brain Injuries to Increased Alzheimer’s Disease Risk Recent research from The Ohio State University Wexner Medical Center has provided compelling evidence that...
GLP-1s Beyond Weight Loss and Diabetes: Exploring New Therapeutic Frontiers
The potential health benefits of GLP-1 (glucagon-like peptide-1) drugs, known for their use in weight loss and diabetes management, are expanding. Novo Nordisk recently revealed that...